JNJ

188.88

+0.3%↑

ABT

124.09

-0.58%↓

TMO

562.55

-0.1%↓

ISRG

536.17

+0.44%↑

DHR

215.69

-0.25%↓

JNJ

188.88

+0.3%↑

ABT

124.09

-0.58%↓

TMO

562.55

-0.1%↓

ISRG

536.17

+0.44%↑

DHR

215.69

-0.25%↓

JNJ

188.88

+0.3%↑

ABT

124.09

-0.58%↓

TMO

562.55

-0.1%↓

ISRG

536.17

+0.44%↑

DHR

215.69

-0.25%↓

JNJ

188.88

+0.3%↑

ABT

124.09

-0.58%↓

TMO

562.55

-0.1%↓

ISRG

536.17

+0.44%↑

DHR

215.69

-0.25%↓

JNJ

188.88

+0.3%↑

ABT

124.09

-0.58%↓

TMO

562.55

-0.1%↓

ISRG

536.17

+0.44%↑

DHR

215.69

-0.25%↓

Search

Pfizer

Abierto

SectorSanidad

24.58 0.9

Resumen

Variación precio

24h

Actual

Mínimo

24.15

Máximo

24.69

Métricas clave

By Trading Economics

Ingresos

-45M

2.9B

Ventas

938M

15B

P/B

Media del Sector

13.106

37.003

BPA

0.78

Rentabilidad por dividendo

6.87

Margen de beneficios

19.982

Empleados

81,000

EBITDA

266M

5.3B

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+17.74% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

6.87%

2.25%

Próximas Ganancias

4 nov 2025

Fecha Próximo Dividendo

1 dic 2025

Próxima Fecha de Ex Dividendo

7 nov 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

7.1B

141B

Apertura anterior

23.68

Cierre anterior

24.58

Noticias sobre sentimiento de mercado

By Acuity

42%

58%

137 / 373 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Pfizer Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

30 oct 2025, 12:38 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Seeks to Outmuscle Pfizer With Up to $9 Billion Bid for Metsera -- 2nd Update

30 oct 2025, 11:03 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Seeks to Muscle Out Pfizer With Up to $9 Billion Bid for Metsera -- Update

30 oct 2025, 10:36 UTC

Principales Movimientos del Mercado
Adquisiciones, fusiones, absorciones

Metsera Shares Leap Premarket as Novo Nordisk Looks to Outbid Pfizer

30 oct 2025, 10:30 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Moves to Outbid Pfizer With Up to $9 Billion Offer for Obesity Drug Developer Metsera

30 oct 2025, 18:11 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Tries to Snatch a Weight-Loss Biotech From Pfizer. There Are Political Risks. -- Barrons.com

30 oct 2025, 16:52 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Seeks to Outmuscle Pfizer With $9 Billion Bid for Metsera -- WSJ

30 oct 2025, 16:52 UTC

Adquisiciones, fusiones, absorciones

Metsera Was Previously in Exclusive Talks with Bristol-Myers Squibb, Sources Say -- WSJ

30 oct 2025, 15:09 UTC

Adquisiciones, fusiones, absorciones

Metsera Stock Soars. Novo Nordisk Looks to Outbid Pfizer for the Obesity-Drug Maker. -- Barrons.com

30 oct 2025, 14:00 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Metsera, Pfizer Debate Superiority of Novo Bid -- Market Talk

30 oct 2025, 13:49 UTC

Ganancias

Merck Stock Falls. Sales of Key Products Missed Estimates. -- Barrons.com

30 oct 2025, 13:44 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Seeks to Outmuscle Pfizer With $9 Billion Bid for Metsera -- 4th Update

30 oct 2025, 13:39 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Novo Nordisk's Pursuit of Metsera Could Be a Sore Loss For Pfizer -- Market Talk

30 oct 2025, 13:22 UTC

Ganancias

Eli Lilly Stock Rises on Earnings as Investors Await Trump Drug Pricing Deal -- Barrons.com

30 oct 2025, 13:22 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Seeks to Outmuscle Pfizer With $9 Billion Bid for Metsera -- 3rd Update

30 oct 2025, 12:42 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Pfizer Raises Antitrust Issues With Novo's Metsera Bid -- Market Talk

30 oct 2025, 12:37 UTC

Adquisiciones, fusiones, absorciones

Metsera Stock Soars. Novo Nordisk Looks to Outbid Pfizer for the Obesity-Drug Maker. -- Barrons.com

30 oct 2025, 11:13 UTC

Ganancias

Eli Lilly Stock Rises on Earnings as Investors Await Trump Drug Pricing Deal -- Barrons.com

30 oct 2025, 11:11 UTC

Adquisiciones, fusiones, absorciones

Metsera Stock Soars. Novo Nordisk Looks to Outbid Pfizer for the Obesity-Drug Maker. -- Barrons.com

30 oct 2025, 11:10 UTC

Adquisiciones, fusiones, absorciones

Metsera: May Negotiate With Pfizer on Potential Adjustments to Transaction >MTSR PFE

30 oct 2025, 11:09 UTC

Adquisiciones, fusiones, absorciones

Metsera: Pfizer Merger Agreement Remains in Effect >MTSR PFE

30 oct 2025, 11:09 UTC

Adquisiciones, fusiones, absorciones

Metsera: Board Determines Novo Nordisk Bid Constitutes Superior Proposal as Defined in Merger Pact With Pfizer >MTSR

30 oct 2025, 10:58 UTC

Ganancias

Eli Lilly Stock Rises on Earnings as Investors Await Trump Drug Pricing Deal -- Barrons.com

30 oct 2025, 10:51 UTC

Ganancias

Merck Stock Falls After Earnings. Keytruda Sales Top $8 Billion for First Time. -- Barrons.com

30 oct 2025, 09:58 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Proposal Is Currently Subject to Review by Metsera Board

30 oct 2025, 09:57 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Offer Also Includes Contingent Value Rights For Up to $21.25 a Share Based on Milestone

30 oct 2025, 09:57 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Offers $56.50 a Share, Giving Metsera Aggregated Equity Value of $6.5B

30 oct 2025, 09:55 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Submits Proposal to Buy Metsera

23 oct 2025, 15:15 UTC

Ganancias

Medpace Holdings' Good Quarter Is Another Sign Biotech Is Back -- Barrons.com

13 oct 2025, 09:33 UTC

Acciones populares

Stocks to Watch Monday: MP Materials, AMD, Nvidia, Alibaba -- WSJ

11 oct 2025, 00:18 UTC

Adquisiciones, fusiones, absorciones

Why Biotech May Be Back -- Barrons.com

Comparación entre iguales

Cambio de precio

Pfizer previsión

Precio Objetivo

By TipRanks

17.74% repunte

Estimación a 12 Meses

Media 28.6 USD  17.74%

Máximo 34 USD

Mínimo 24 USD

De acuerdo con 17 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Pfizer Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

17 ratings

4

Comprar

12

Mantener

1

Vender

Puntuación técnica

By Trading Central

22.855 / 23.85Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

137 / 373 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
help-icon Live chat